
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 February 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study”, Pancreatology, 2019.
, “Use of anti-malarial drugs and the risk of developing eye disorders”, Travel Med Infect Dis, vol. 12, pp. 40-7, 2014.
, “Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 514-24, 2009.
, “Risk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations”, Climacteric, vol. 12, pp. 445-53, 2009.
, “Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study”, Ann Intern Med, vol. 152, pp. 78-84, 2010.
, “Reflux disease, gastrointestinal ulcer or weight loss in patients with COPD”, Copd, vol. 7, pp. 172-8, 2010.
, “The Potential of Glycemic Control and Body Weight Change as Early Markers for Pancreatic Cancer in Patients With Long-standing Diabetes Mellitus: A Case-Control Study”, PancreasPancreasPancreas, vol. 47, pp. 807-815, 2018.
, “Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
, “Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 56-65, 2016.
, “COPD and the risk of depression”, Chest, vol. 137, pp. 341-7, 2010.
, “Colorectal cancer and markers of anemia”, Eur J Cancer Prev, vol. 27, pp. 530-538, 2018.
, “Chronic obstructive pulmonary disease and the risk of cardiovascular diseases”, Eur J Epidemiol, vol. 25, pp. 253-60, 2010.
, “Cataract in patients with diabetes mellitus-incidence rates in the UK and risk factors”, Eye (Lond), vol. 32, pp. 1028-1035, 2018.
, “Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study”, J Clin Endocrinol Metab, 2019.
, “Antimalarial chemoprophylaxis and the risk of neuropsychiatric disorders”, Travel Med Infect Dis, vol. 11, pp. 71-80, 2013.
,